Sun, Nov 23, 2014, 11:22 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Senomyx Inc. Message Board

  • shapiro.sanford shapiro.sanford Jul 28, 2011 9:03 AM Flag

    Limbo Rock

    The recent downfall in the price of SNMX reminds me of the "Limbo Rock" song. ...Limbo now, how low can you go? I say around $4.50...maybe time to dump or be patient and buy some more?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This has become a trading stock, really. I agree that it's probably headed lower in the short term, but if you're a long, then just wait it out.

      Any idea when they're reporting earnings? Also, I have to say, based on nothing but my own speculation, that this company is a takeover target. Market cap is just a bit over $200M, which is very cheap in light of the large upfront payments they've received in recent years from Firmenich and Pepsi. I would assume that if the sucrose enhancer product is as successful as many of us seem to think it is, then Firmenich would be due to pay SNMX lots of royalties in future years. So why not just buy out SNMX, enabling them access to all the other enhancers as well?

      I've also got some questions/concerns about the bitter blocker products. SNMX has now received GRAS approval on a couple of them, and yet there's no commercial partner lined up on these. So either the products are worthless or SNMX is holding out for a good deal (something along the lines of what they got with Firmenich and Pepsi). Or, a potential partner could be scared off by the recent stem-cell abortion headlines. Regardless, it seems like a big company like Firmenich (which is no doubt performing the same types of testing procedures themselves) could simply absorb SNMX, and the problem would basically go away.

 
SNMX
5.33-0.060(-1.11%)Nov 21 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Campbell Soup Company
NYSEFri, Nov 21, 2014 4:04 PM EST
Exa Corporation
NasdaqGMFri, Nov 21, 2014 3:59 PM EST